METHODS OF TREATING CHRONIC KIDNEY DISEASE WITH DAPAGLIFLOZIN

Abstract: the present disclosure is directed to methods of treating patients with chronic kidney disease (ckd), with and without type 2 diabetes, with an sglt2 inhibitor, such as dapagliflozin.

Inventor(s): Anna Maria LANGKILDE

CPC Classification: A61K31/7004 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250161339